HOME > NATION > Article

Text Size

small

medium

large


Japan Team to Start iPS Clinical Trials for Neck Cancer

Japan Team to Start iPS Clinical Trials for Neck Cancer

   Tokyo, June 29 (Jiji Press)--Chiba University and Japanese government-affiliated research institute Riken said Monday that they will launch clinical trials for treating head and neck cancer using killer cells produced from induced pluripotent stem, or iPS, cells.
   In the trials led by doctors, the Japanese university and Riken will create natural killer T, or NKT, cells, which attack cancer cells, from iPS cells and inject them into patients.
   This will be the first clinical trial or research in Japan to use cells made from iPS cells for cancer treatment. Also, transplanting iPS cell-derived NKT cells will be the first in the world.

To read a full story, please click here to find out how to subscribe.

NATION

Aomori Tourism Information

HEADLINES

POLITICS
Toyama Governor Race to Kick Off on Oct. 8 for Voting on Oct. 25
ECONOMY
Tokyo Area Condo Supply in 2020 1st Half Drops 44% to Record Low of 7,497 Units
SPORTS
Gymnastics Women: Teramoto Steadily Recovering from Achilles Tendon Rupture
OTHER
Haneko Takayama, Haruka Tono Each Win Akutagawa Prize, Seishu Hase Naoki Prize

AFP-JIJI PRESS NEWS JOURNAL


Photos